000 | 03276cam a2200493M 4500 | ||
---|---|---|---|
001 | 9781003330271 | ||
003 | FlBoTFG | ||
005 | 20240213122827.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 221005s2022 xx o 0|| 0 eng d | ||
040 |
_aOCoLC-P _beng _cOCoLC-P |
||
020 |
_a9781000781243 _q(electronic bk.) |
||
020 |
_a1000781240 _q(electronic bk.) |
||
020 |
_a9781003330271 _q(electronic bk.) |
||
020 |
_a1003330274 _q(electronic bk.) |
||
020 |
_a9781000781298 _q(electronic bk. : EPUB) |
||
020 |
_a1000781291 _q(electronic bk. : EPUB) |
||
020 | _z103235223X | ||
020 | _z9781032352237 | ||
020 | _z9781032361055 | ||
020 | _z1032361050 | ||
024 | 7 |
_a10.4324/9781003330271 _2doi |
|
035 | _a(OCoLC)1346535953 | ||
035 | _a(OCoLC-P)1346535953 | ||
050 | 4 | _aHD9666.5 | |
072 | 7 |
_aBUS _x070130 _2bisacsh |
|
072 | 7 |
_aBUS _x070170 _2bisacsh |
|
072 | 7 |
_aBUS _x108000 _2bisacsh |
|
072 | 7 |
_aKJMV6 _2bicssc |
|
082 | 0 | 4 |
_a338.4/361510973 _223/eng/20220527 |
100 | 1 |
_aSmith, Brian D. _c(Author of New drugs, fair prices), _eauthor. |
|
245 | 1 | 0 |
_aNEW DRUGS, FAIR PRICES _h[electronic resource] : _bmanaging the pharmaceutical innovation ecosystem for... sustainable and affordable new medicines. |
260 |
_a[S.l.] : _bROUTLEDGE, _c2022. |
||
300 | _a1 online resource | ||
520 | _aNew Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with the others, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently. | ||
588 | _aOCLC-licensed vendor bibliographic record. | ||
650 | 0 |
_aDrugs _xPrices _zUnited States. |
|
650 | 0 |
_aPrescription pricing _zUnited States. |
|
650 | 0 |
_aPharmaceutical industry _zUnited States. |
|
650 | 0 |
_aDrugs _zUnited States _xCost control. |
|
856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781003330271 |
856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
999 |
_c5274 _d5274 |